1. India Stocks

  2. •

    Basic Materials

  3. •

    Agricultural Inputs
E.I.D.- Parry (India) Limited

E.I.D.- Parry (India) Limited

EIDPARRY.NS
E.I.D.- Parry (India) LimitedIN flagNational Stock Exchange of India
755.95
INR
+6.75
- -
134.53BMarket Cap
E.I.D.- Parry (India) Limited
EIDPARRY.NS
(National Stock Exchange of India)

Recent

price

755.95

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
541.24
438.76
478.79
521.78
607.48
673.19
669.54
711.6
750.97
774.64
853.18
939.62
1,165.38
1,193.94
1,780.24
2,167.09
2,167.43
Revenue per Share
32.09
18.03
11.91
4.44
6.64
1.95
29.44
14.46
8.67
26.43
25.27
51.17
53.39
50.68
49.47
32.03
32.03
Basic EPS, GAAP
-1.75
-4.76
21.9
71.58
0.91
13.04
102.5
3.82
-22.85
91.59
250.64
103.19
-28.25
56.3
50.13
-4.27
- -
Free Cash Flow per Basic Share
16.13
10.27
12.58
4.15
10.2
3.44
7.88
7.89
12.44
2.75
12.59
19.67
13.89
12.86
8.69
12.99
- -
Dividend per Share
129.62
139.75
1.01
1
1
0.99
0.99
8.26
0.28
16.79
81.82
122.78
170.42
212.61
260.24
1
1
Book Value per Share
165.52
164
161.98
166.54
181.16
187.97
215.87
235.54
247.86
291.25
382.78
453.83
534.16
610.37
706.87
741.63
741.51
Tangible Book Value per Share
173
173
174
176
176
177
177
177
177
177
177
177
177
178
178
178
178
Basic Weighted Avg Shares
93,602
76,101
83,216
91,719
106,797
119,081
118,464
125,936
132,917
137,108
151,032
166,533
206,815
211,946
316,086
385,341
385,460
Sales/Revenue/Turnover
11.17
16.1
12.67
10.31
9.13
6.61
11.2
8.64
9.84
12.27
12.46
12.73
13.64
10.67
6.88
6.97
6.97
Operating Margin (%)
1,742
1,896
2,152
2,261
2,441
2,496
2,480
2,513
2,723
3,190
4,161
3,340
3,765
4,208
5,124
7,631
7,631
Depreciation Expense
5,550
3,127
2,069
780
1,168
345
5,208
2,558
1,535
4,679
4,474
9,068
9,475
8,997
8,784
5,695
5,695
Net Income, GAAP
32.59
33.62
29.95
30.7
39.3
45.05
22.98
40.4
47.71
29.8
35.05
26.09
28.72
25.64
27.79
34.37
34.37
Effective Tax Rate (%)
5.93
4.11
2.49
0.85
1.09
0.29
4.4
2.03
1.15
3.41
2.96
5.45
4.58
4.24
2.78
1.48
1.48
Profit Margin (%)
9,212
9,646
9,928
6,479
4,713
4,728
9,440
8,816
10,907
18,578
31,282
37,318
41,222
58,868
59,236
55,392
55,392
Working Capital
8,988
13,964
20,176
15,641
11,334
10,267
8,426
4,100
4,521
10,295
4,794
4,813
5,066
6,435
7,682
7,720
7,720
LT Debt
29,728
33,516
33,661
33,483
32,904
34,268
38,880
42,364
44,525
52,263
68,287
80,999
95,390
112,120
129,315
149,196
149,196
Total Equity
12.15
11.65
8.99
8.13
7.53
5.18
12.54
7.94
7.58
12.48
14.09
18.28
19.82
14.1
11.1
9.05
9.05
Return on Invested Capital (%)
7.85
3.78
3.89
3.01
3.61
2.12
11.36
3.31
1.33
5.28
0.64
6.08
3.68
4.25
2.3
0.42
0.42
Return on Capital (%)
27.63
13.41
16.95
443.52
664.33
196.3
2,961.67
312.57
203.34
309.77
51.26
50.04
36.44
26.47
20.93
24.56
24.56
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
17,969
- -
77,782
LT Borrowings
2,864
- -
1,449
LT Finance Leases
5,825
- -
6,271
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
178
- -
178
Market Capitalization
182,226
183,927
137,916

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
199,036
- -
187,465
Cash, Cash Equivalents & STI
50,254
- -
36,215
Accounts Receivable, Net
26,580
- -
23,614
Inventories
70,852
- -
86,607
Total Current Liabilities
141,961
- -
132,073
Payables & Accruals
- -
- -
- -
ST Debt
17,969
- -
77,782
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
16.02%
16.93%
15.37%
Free Cash Flow
-104.02%
-121%
-108.52%
Net Income, GAAP
158.33%
12.92%
-35.16%
Sales/Revenue/Turnover
13.26%
21.6%
21.91%
Total Cash Common Dividend
50.38%
7.42%
49.75%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
70,264
90,595
77,701
-26,615
211,946
2025
67,468
93,304
87,204
68,111
316,086
2026
87,237
116,244
103,156
78,823
385,341

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6.13
25.48
6.66
- -
50.68
2025
5.14
17.22
10.97
16.14
49.47
2026
13.85
23.87
13.05
-18.74
32.03

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
12.86
2025
- -
- -
- -
- -
8.69
2026
- -
- -
- -
- -
12.99
Similar Companies
KSE Limited (KSE.NS)
Guangxi Hechi Chemical Co., Ltd (000953.SZ)
China BlueChemical Ltd. (CBLUF)
ShanDong Cynda Chemical Co.,Ltd (603086.SS)
U.S. Energy Initiatives Corporation Inc. (USEI)
Hailir Pesticides and Chemicals Group Co.,Ltd. (603639.SS)
Business
E.I.D.-Parry (India) Limited manufactures and markets sugar, nutraceuticals, ethanol, co-generated power, and related products primarily in South India. The company produces a range of sweeteners including white sugar, refined sugar, pharma grade sugar, brown sugar, low GI sugar, and jaggery in bulk and retail packs under brands such as Parrys Pure and Parrys Superbrand; nutraceuticals comprising organic spirulina (Parrys Spirulina), micro algal products, natural beta carotenoids, and phycocyanin; distillery products such as rectified spirit, extra neutral alcohol, and ethanol from B-heavy molasses and syrup; and surplus power from cogeneration facilities. It operates seven sugar plants with 40,300 TCD crushing capacity, 140 MW cogeneration capacity, and 598 KLPD distillery capacity located at Nellikuppam, Pugalur, and Sivaganga in Tamil Nadu; Sankili in Andhra Pradesh; and Bagalkot, Haliyal, and Ramdurg in Karnataka; alongside nutraceutical plants at Oonaiyur and Saveripuram in Tamil Nadu. Founded in 1788 and headquartered at Dare House in Chennai, India, E.I.D.-Parry forms part of the Murugappa Group and maintains presence in refined sugar via Parry Sugar Refinery India Pvt. Ltd. and farm inputs including bio-pesticides through subsidiary Coromandel International Limited, with nutraceuticals sold in over 41 countries. Recent developments include the September 2025 board approval to divest its entire 50% stake in joint venture Algavista Greentech Private Limited to partner Synthite Industries for Rs 8 crore, following the joint venture's establishment for phycocyanin production; declassification of two promoter entities into public shareholders; initiation of ethanol production from B-heavy molasses at Nellikuppam; and ongoing expansions in low GI sugar and sustainable sugarcane practices.